Kymera Therapeutics, Inc. (KYMR) Earnings
NASDAQ·Healthcare·Biotechnology
$105.46
-0.66%
Mkt Cap $9.05B
EPS — Estimate vs Actual
Mkt Cap
$9.05B
P/E
—
Fwd P/E
—
P/S
175.90
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$105.46
-0.66%
Mkt Cap $9.05B
Mkt Cap
$9.05B
P/E
—
Fwd P/E
—
P/S
175.90
Rev TTM
—
EPS TTM
-$3.58